Skip to main content

Published locations for Other therapy options may relegate omacetaxine to last-line choice for chronic or accelerated phase CML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Other therapy options may relegate omacetaxine to last-line choice for chronic or accelerated phase CML

User login

  • Reset your password
  • /content/other-therapy-options-may-relegate-omacetaxine-last-line-choice-chronic-or-accelerated-phase
  • /jcso/article/130762/other-therapy-options-may-relegate-omacetaxine-last-line-choice-chronic-or
  • /hematology-oncology/article/130762/other-therapy-options-may-relegate-omacetaxine-last-line-choice